Cardiovascular Disease Markers in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to Everolimus.

被引：0
|
作者：
Schiavelli, R. [1 ]
Cuevas, C. [1 ]
Alvarenga, E. [1 ]
Ponte, M. [1 ]
Otero, A. [2 ]
Margulis, F. [1 ]
机构：
[1] Hosp Argerich, Unidad Nefrol & Trasplante Renal, Buenos Aires, DF, Argentina
[2] Novartis Argentina SA, Med, Caba, Argentina
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：315 / 315
页数：1
相关论文
共 50 条
  • [1] Conversion from calcineurin inhibitors to everolimus in kidney transplant recipients with malignant neoplasia
    Fernandez, A.
    Marcen, R.
    Pascual, J.
    Galeano, C.
    Ocana, J.
    Arellano, E. M.
    Alfaro, C.
    Villafruela, J. J.
    Burgos, F. J.
    Ortuno, J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (08) : 2453 - 2455
  • [2] EVEROLIMUS (EVE) IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN INHIBITORS (CNI) IMMUNOSUPPRESSION TREATMENT
    Rengel, Manuel
    Abad, Soraya
    Vega, Almudena
    Verdalles, Ursula
    Verde, Eduardo
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 39 - 40
  • [3] Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus.
    Ueno, P.
    Tedesco, H.
    Brigido, A.
    Felipe, C.
    Hannun, P.
    Cristelli, M.
    Aguiar, W.
    Medina-Pestana, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 679 - 679
  • [4] Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients
    Felipe, Claudia
    Ferreira, Alexandra
    Bessa, Adrieli
    Abait, Tamiris
    Perez, Juliana D.
    Casarini, Dulce Elena
    Medina-Pestana, Jose
    Tedesco, Helio
    [J]. THERAPEUTIC DRUG MONITORING, 2018, 40 (01) : 52 - 58
  • [5] EVEROLIMUS (EVE) IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN INHBITORS (CNI) IMMUNOSUPPRESSION TREATMENT
    Rengel, Manuel
    Tana, Lorena
    Quiroga-Gilis, Borja
    Reque, Javier
    Panizo, Nayara
    Bucalo, Laura
    Verdalles, Ursula
    Abad, Soraya
    Vega, Almudena
    Verde, Eduardo
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 283 - 283
  • [6] Non-melanoma skin cancer outcomes in kidney transplant recipients converted from calcineurin inhibitors to mTOR inhibitors: a systematic review
    Olszewska, Berenika
    Imko-Walczuk, Beata
    Debska-Slizien, Alicja
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (02): : 187 - 193
  • [7] Evaluation of Torque Teno Virus DNA Load as a Predictive Biomarker in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to Belatacept
    Cabezas, Lara
    Truffot, Aurelie
    Germi, Raphaele
    Bugnazet, Mathilde
    Malvezzi, Paolo
    Gnesotto, Manon
    Rostaing, Lionel
    Jouve, Thomas
    Noble, Johan
    [J]. KIDNEY INTERNATIONAL REPORTS, 2024, 9 (06): : 1718 - 1729
  • [8] Everolimus Associated With Low-Dose Calcineurin Inhibitors, an Option in Kidney Transplant Recipients of Very Old Donors
    Furian, L.
    Silvestre, C.
    Vallese, L.
    Baldan, N.
    Donato, P.
    Bonfante, L.
    Cavallin, F.
    Marchini, F.
    Rigotti, P.
    [J]. TRANSPLANTATION PROCEEDINGS, 2014, 46 (10) : 3390 - 3395
  • [9] Conversion from sirolimus to everolimus in kidney transplant recipients receiving a calcineurin-free regimen
    Carvalho, Catarina
    Coentrao, Luis
    Bustorff, Manuela
    Patricio, Emilia
    Sampaio, Susana
    Santos, Joana
    Oliveira, Gerardo
    Pestana, Manuel
    [J]. CLINICAL TRANSPLANTATION, 2011, 25 (04) : E401 - E405
  • [10] The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
    Emel Isiktas Sayilar
    Alparslan Ersoy
    Canan Ersoy
    Aysegul Oruc
    Yavuz Ayar
    Deniz Sigirli
    [J]. BMC Nephrology, 23
12345